Adam O'Dell reveals details on the tiny company Big Pharma can't stop paying.
Dear Reader,
Adam O'Dell left medical school over 20 years ago. He's been showing readers winning trades ever since.
His recent Adaptive Biotechnologies recommendation is currently sitting at 280% — in just 24 months.
Today, he's revealing his top biotech stock to own right now.
In Adam's words: "A small Boston-based biotech has cracked the problem that's defeated medicine for 140 years — and Big Pharma is already writing billion-dollar checks to access their technology."
In this new video, Adam reveals details on the company at the center of it all — with a patent-fortress protecting a medical breakthrough he expects to blossom into a $1 trillion industry.
(c) 2026 Banyan Hill Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Banyan Hill Publishing. 702 Cathedral Street, Baltimore, MD 21201. (TEL: 866-584-4096) Legal Notice
The mailbox associated with this email address is not monitored, so please do not reply. However, your feedback is very important to us so if you would like to contact us, please click here.
Post a Comment
Post a Comment